Keywords
How to Cite
Abstract
Breast cancer cT1-4N0M0 patients usually require a sentinel lymph node biopsy. Sentinel lymph node biopsy with indocyanine green fluorescence detection is a modern technique with a high lymph node detection rate. However, the false-negative rate was not evaluated adequately. Our objective was to determine node detection rate and the false-negative rate. 99 patients with 100 cases of breast cancer cT1-4N0M0 were operated on. The axillary part of an operation consisted of indocyanine green fluorescence-guided SLN biopsy and an axillary lymphadenectomy of levels I-II or I-П-Ш. A signal lymph node was detected in 98 cases (98 %). In 28 (28.6%) cases out of 98, metastases in signal lymph nodes were found. Other than sentinel lymph node had metastatic lesion only in 35.7% in SLN N+ cases. False negative result occurred in 1 case of 28 (3.6%). The application of indocyanine green fluorescence-guided sentinel lymph node biopsy in cN0 breast cancer patients allows for a high signal lymph node detection rate and a low false negative rate.References
Вельшер Л.З., Решетов Д.Н., Габуния З.Р., и др. Сторожевые лимфатические узлы при раке молочной железы // Маммология. - 2007. - № 1. - C. 23-25.
Петровский А.В., Афанасьева К.В., Гончаров М.О. и др. использование различных радиофармпрепаратов при биопсии сторожевых лимфатических узлов у больных раком молочной железы // Радиационная онкология и ядерная медицина. - 2013. - № 1. - C. 85-89.
Криворотько П.В., Канаев С.В., Семиглазов В.Ф. и др. Методологические проблемы биопсии сигнальных лимфатических узлов у больных раком молочной железы // Вопросы онкологии. - 2015. - Т. 61. - № 3. - C. 418-423.
Ansari B., Ogston S.A., Purdie C.A. et al. Meta-analysis of sentinel node biopsy in ductal carcinoma in situ of the breast // Br. J. surg. - 2008. - Vol. 95. - P 547-554.
Ballardini B., Santoro L., Sangalli C. et al. The indocyanine green method is equivalent to the "mTc-labeled radiotracer method for identifying the sentinel node in breast cancer: a concordance and validation study // Eur. J. surg. oncol. - 2013. - Vol. 39. - P 1332-1336.
Cabanas R. An approach for the treatment of penile carcinoma // Cancer. - 1977. - Vol. 39. - P 456-466.
Canavese G., Catturich A., Vecchio C. et al. sentinel node biopsy compared with complete axillary dissection for staging early breast cancer with clinically negative lymph nodes: results of randomized trial // Ann. oncol. - 2009. - Vol. 20. - P 1001-1007.
Coates A.S., Winer E.P., Goldhirsch A. et al. Tailoring therapies-improving the management of early breast cancer: st Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 // Ann Oncol. - 2015. - Vol. 26. - P 1533-1546.
Curigliano G., Burstein H.J., Winer E.P. et al. De-escalating and escalating treatments for early-stage breast cancer: the st. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 // Ann Oncol. - 2017. - Vol. 28. - P 1700-1712.
Giammarile F., Alazraki N., Aarsvold J.N. et al. The EANM and sNMMI practice guideline for lymphoscintigraphy and sentinel node localization in breast cancer // Eur. J. Nucl. Med. Mol. Imaging. - 2013. - Vol. 40. - P 1932-1947.
Gould E.A., Winship T., Philbin P.H., Kerr H.H. Observations on a "sentinel node" in Cancer of the parotid // Cancer. - 1960. - Vol. 13. - P 77-78.
Hojo T., Nagao T., Kikuyama M. et al., Evaluation of sentinel node biopsy by combined fluorescent and dye method and lymph flow for Breast cancer // Breast. - 2010. - Vol. 19. - P 210-213.
Karakatsanis A., Christiansen P.M., Fischer L. et al. The Nordic sentiMag trial: a comparison of super paramagnetic iron oxi de (sPIO) nanoparticles versus Tc(99) and patent blue in the detection of sentinel node (sN) in patients with breast cancer and a meta-analysis of earlier studies // Breast Cancer Res Treat. - 2016. - Vol. 157. - P 281-294.
Kitai T., Inomoto T., Miwa M., Shikayama T. Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in Breast Cancer // Breast Cancer. - 2005. - Vol. 12. - P 211-215.
Krag D.N., Anderson S.J., Julian T.B. et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NsABP B-32 randomised phase 3 trial // Lancet Oncol. - 2010. - Vol. 11. - P 927-933.
Motomura K., Inaji H., Komoike Y. et al. sentinel node biopsy guided by indocyanine green dye in breast cancer patients // Jpn J. Clin. Oncol. - 1999. - Vol. 29. - P 604-607.
Murawa D., Hirche C., Dresel S., H Nerbein M. Sentinel lymph node biopsy in breast cancer guided by indocyanine green fluorescence // Br. J. surg. - 2009. - Vol. 96. - P 1289-1294.
Petrelli F., Lonati V., Barni S. Axillary dissection compared to sentinel node biopsy for the treatment of pathologically node-negative breast cancer: a meta-analysis of four randomized trials with long-term follow up // Oncol. Rev. - 2012. - Vol. 6. - e20.
Vera D.R., Wallace A.M., Hoh C.K. A synthetic macromolecule for sentinel node detection: (99m)Tc-DTPA-mannosyl-dextran // J. Nucl. Med. - 2001. - Vol. 42. - P 951-959.
Veronesi U., Paganelli G., Viale G. et al. A Randomized Comparison of sentinel-Node Biopsy with Routine Axillary Dissection in Breast Cancer // N. Engl. J. Med. - 2003. - Vol. 349. - P 546-553.
Veronesi U., Viale G., Paganelli G. et al. sentinel lymph node biopsy in breast cancer: ten year results of a randomized controlled study // Ann surg. - 2010. - Vol. 251. - P 595-600.
Wang Z., Wu L.C., Chen J.Q. sentinel lymph node biopsy compared with axillary lymph node dissection in early breast cancer: a meta-analysis // Breast Cancer Res Treat. - 2011. -Vol. 129. - P 675-689.
Wishart G.C., Loh S.W., Jones L., Benson J.R. A feasibility study (ICG-10) of indocyanine green (ICG) fluorescence mapping for sentinel lymph node detection in early breast cancer // Eur. J. surg. Oncol. - 2012. - Vol. 38. - P 651-656.
Xiong L., Gazyakan E., Yang W. et al. Indocyanine green fluorescence-guided sentinel node biopsy: a metaanalysis on detection rate and diagnostic performance // Eur. J. surg. Oncol. -2014. - Vol. 40. - P 843-849.
Zavagno G., De salvo G.L., Scalco G. et al. A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the sentinella/GIVOM trial // Ann surg. - 2008. - Vol. 247. - P 207-213.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
© АННМО «Вопросы онкологии», Copyright (c) 2019